Your browser doesn't support javascript.
loading
Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC.
Gerger, Armin; Eisterer, Wolfgang; Fuxius, Stefan; Bastian, Sara; Koeberle, Dieter; Welslau, Manfred; Sanoyan, Dilara Akhoundova; Maas, Christian; Uhlig, Jens; Fenchel, Klaus; Greil, Richard; VON DER Heyde, Eyck; Agocs, Gaëlle Rhyner; Weide, Rudolf; Schwager, Monika; Reichenbach, Frank; Modest, Dominik Paul; Fritsch, Ralph.
Afiliação
  • Gerger A; Division of Clinical Oncology, Medical University of Graz, Graz, Austria; armin.gerger@medunigraz.att.
  • Eisterer W; Department of Internal Medicine, Hematology and Oncology, Klagenfurt Hospital, Klagenfurt, Austria.
  • Fuxius S; Practice for Oncology, Heidelberg, Germany.
  • Bastian S; Department of Internal Medicine, Medical Oncology and Hematology, Canton Hospital Graubünden, Chur, Switzerland.
  • Koeberle D; Cancer Centre, St. Claraspital, Basel, University Berne, Bern, Switzerland.
  • Welslau M; Hematology and Internal Oncology, Aschaffenburg, Germany.
  • Sanoyan DA; Department of Medical Oncology and Haematology, University Hospital Zurich, Zurich, Switzerland.
  • Maas C; Medical Practice for Hemato-Oncology, Halberstadt, Germany.
  • Uhlig J; Practice for Internal Medicine, Hematology and Oncology, Naunhof, Germany.
  • Fenchel K; Medical Practice for Internal Oncology and Hematology, Saalfeld, Germany.
  • Greil R; Salzburg Cancer Research Institute - Center for Clinical Cancer and Immunology Trials, Cancer Cluster Salzburg, Paracelsus Medical University, Salzburg, Austria.
  • VON DER Heyde E; Oncological Study Center at Raschplatz, Hannover, Germany.
  • Agocs GR; Department for Medical Oncology, HFR Canton Hospital Fribourg, Fribourg, Switzerland.
  • Weide R; Institut for Health Services Research in Oncology, Koblenz, Germany.
  • Schwager M; Winicker Norimed GmbH - Clinical Research, Berlin, Germany.
  • Reichenbach F; Pierre Fabre Pharma GmbH, Freiburg, Germany.
  • Modest DP; Department of Hematology, Oncology and Cancer Immunology (CVK), Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Fritsch R; Department of Medical Oncology and Haematology, University Hospital Zurich, Zurich, Switzerland.
Anticancer Res ; 42(10): 4773-4785, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36191968
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas B-raf Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas B-raf Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article